Displaying 41 - 60 of 1603
Novartis Pharmaceuticals Corp.
FTC Approves Final Order with Welsh Carson
Welsh, Carson, Anderson & Stowe, In the Matter of
Illinois and Minnesota Join FTC Lawsuit Challenging Medical Device Coatings Deal
B4B Corp.
The Federal Trade Commission, jointly with the Department of Justice and the U.S. Food and Drug Administration, have sued a New York-based marketer of herbal tea, seeking to permanently block deceptive ads that claim its Earth Tea is clinically proven to treat, cure, and prevent COVID-19.
FTC Staff Reaffirm Opposition to Proposed Indiana Hospital Merger
FTC Challenges Medical Device Coatings Deal
Welsh, Carson, Anderson & Stowe; Analysis of Agreement Containing Consent Order To Aid Public Comment
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya In the Matter of Welsh, Carson, Anderson & Stowe
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
FTC Secures Settlement with Private Equity Firm in Antitrust Roll-Up Scheme Case
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
FTC Announces Refund Claims Process for Consumers Who Bought Deceptively Marketed Golden Sunrise Nutraceutical Products
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
FTC Staff Sends Warning Letters to Healthcare Plan Marketers and Lead Generators
Displaying 41 - 60 of 1603